PSMA靶向治疗 2 FDA扩大Illuccix标签，纳入在紫杉醇前环境中进行RLT的患者选择 2025/06/23 FDA greenlights phase 1 trial of theranostic radiopharmaceutical for mCRPC 2025/06/20